Hennion & Walsh Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.89M | Buy |
|
|||||
|
2025
Q2 | $3.84M | Buy |
|
|||||
|
2025
Q1 | $3.65M | Buy |
|
|||||
|
2024
Q4 | $3.06M | Sell |
|
|||||
|
2024
Q3 | $4.01M | Sell |
|
|||||
|
2024
Q2 | $5.7M | Sell |
|
|||||
|
2024
Q1 | $8.63M | Buy |
|
|||||
|
2023
Q4 | $6.23M | Sell |
|
|||||
|
2023
Q3 | $5.25M | Sell |
|
|||||
|
2023
Q2 | $8.68M | Sell |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $13.3M | Sell |
|
|||||
|
2022
Q3 | $3.31M | Sell |
|
|||||
|
2022
Q2 | $4.25M | Sell |
|
|||||
|
2022
Q1 | $7.24M | Buy |
|
|||||
|
2021
Q4 | $5.87M | Sell |
|
|||||
|
2021
Q3 | $5.9M | Buy |
|
|||||
|
2021
Q2 | $7.17M | Buy |
|
|||||
|
2021
Q1 | $8.46M | Buy |
|